Bank of New York Mellon’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $517K | Buy |
54,039
+12,956
| +32% | +$124K | ﹤0.01% | 3468 |
|
|
2025
Q1 | $382K | Sell |
41,083
-3,924
| -9% | -$36.5K | ﹤0.01% | 3565 |
|
|
2024
Q4 | $626K | Buy |
45,007
+2,221
| +5% | +$30.9K | ﹤0.01% | 3383 |
|
|
2024
Q3 | $1.01M | Sell |
42,786
-15,301
| -26% | -$360K | ﹤0.01% | 3130 |
|
|
2024
Q2 | $929K | Buy |
58,087
+14,352
| +33% | +$229K | ﹤0.01% | 3242 |
|
|
2024
Q1 | $717K | Buy |
43,735
+1,790
| +4% | +$29.4K | ﹤0.01% | 3317 |
|
|
2023
Q4 | $581K | Buy |
41,945
+75
| +0.2% | +$1.04K | ﹤0.01% | 3468 |
|
|
2023
Q3 | $577K | Buy |
41,870
+1,074
| +3% | +$14.8K | ﹤0.01% | 3466 |
|
|
2023
Q2 | $695K | Sell |
40,796
-735
| -2% | -$12.5K | ﹤0.01% | 3409 |
|
|
2023
Q1 | $667K | Sell |
41,531
-4,838
| -10% | -$77.7K | ﹤0.01% | 3333 |
|
|
2022
Q4 | $352K | Buy |
46,369
+7,119
| +18% | +$54.1K | ﹤0.01% | 3720 |
|
|
2022
Q3 | $345K | Buy |
39,250
+7,339
| +23% | +$64.5K | ﹤0.01% | 3761 |
|
|
2022
Q2 | $228K | Buy |
31,911
+1,291
| +4% | +$9.22K | ﹤0.01% | 4005 |
|
|
2022
Q1 | $328K | Buy |
30,620
+10,045
| +49% | +$108K | ﹤0.01% | 3966 |
|
|
2021
Q4 | $289K | Buy |
+20,575
| New | +$289K | ﹤0.01% | 4106 |
|